Skip to the main content.

Press | ​Accelerating Timelines Vital to Securing Slice of Biosimilars Market, KBI

Picture of Admin Admin Sep 3, 2017 5:10:00 AM

News

Accelerating timelines vital to securing slice of biosimilars market, KBI

By Dan Stanton+, 24-Aug-2016

Accelerated development gives biosimilars an upper hand in gaining market share, CMO KBI Biopharma told delegates in Korea yesterday.

http://www.biopharma-reporter.com/Upstream-Processing/Expediting-timelines-key-to-securing-slice-of-biosimilars-market-KBI
KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

Admin: Apr 15, 2024 7:55:00 AM

Durham, North Carolina (April 15, 2024) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and...

Read More
KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer

KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer

Admin: Apr 1, 2024 7:55:00 AM

Durham, North Carolina (April 1, 2024) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing...

News
Read More
KBI Biopharma Recognized as a Leader in All Six Categories of the 2024 CDMO Leadership Awards

KBI Biopharma Recognized as a Leader in All Six Categories of the 2024 CDMO Leadership Awards

Picture of KBI Biopharma KBI Biopharma: Mar 21, 2024 11:19:28 AM

KBI Biopharma, a JSR Life Sciences Company and leading global Contract Development and Manufacturing Organization (CDMO) has received six awards in...

News
Read More